BRIEF RESEARCH REPORT article
Front. Genet.
Sec. Genetics of Common and Rare Diseases
Volume 16 - 2025 | doi: 10.3389/fgene.2025.1605440
Autosomal dominant myopathy caused by a novel ISCU variant
Provisionally accepted- 1Maria Sklodowska-Curie Medical Academy, Warsaw, Masovian, Poland
- 2MedGen Medical Centre, Warsaw, Masovian, Poland
- 3University of Parma, Parma, Emilia-Romagna, Italy
- 4Institute of Psychiatry and Neurology (IPiN), Warsaw, Masovian, Poland
- 5University Hospital of Basel, Basel, Basel-Stadt, Switzerland
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Hereditary myopathy with lactic acidosis due to Iron-Sulfur Cluster Assembly Enzyme (ISCU) deficiency is a rare disorder of energy metabolism characterized clinically by myopathy with exercise intolerance, and biochemically by deficiencies of skeletal muscle mitochondrial respiratory chain enzymes. ISCU protein plays an important role in iron-sulphur clusters (Fe-S) assembly and is therefore essential for the activity of mitochondrial Fe-S proteins such as succinate dehydrogenase and aconitase. Recessive hypomorphic ISCU alleles have been associated with hereditary myopathy with lactic acidosis, also known as Swedish-type myopathy. To date, only one heterozygous dominant variant (c.287G>T, p.Gly96Val) in the ISCU gene has been reported as pathogenic. Functional studies have shown that this variant has a detrimental, dominant effect on activity of Fe-S-dependent enzymes. Whole exome sequencing performed in an adult female patient with progressive muscle weakness led to the identification of a novel heterozygous variant c.399del (p.Val134Ter) in the ISCU. This variant is localized in the functional IscU_like domain of the protein, with bioinformatics prediction of damaging effects on protein function. Moreover, the same variant was also found in a few family members, who present signs of myopathy. This novel variant segregates with the disease and results in a phenotype reminiscent of the recessive disease. Yeast Saccharomyces cerevisiae is a widely used tool able to assess the impact of the VUS in a quick and efficient way, therefore functional studies were performed on this model system. The results obtained not only confirm the pathogenetic effect of the variant, but also support its dominant inheritance.
Keywords: Mitochondrial myopathy, Mitochondria, IscU, yeast model, WES
Received: 03 Apr 2025; Accepted: 07 May 2025.
Copyright: © 2025 Rusecka, Ceccatelli Berti, Szczęśniak, Bednarska -Makaruk, Mroczek, Kacprzak, Sobczyńska -Tomaszewska and Goffrini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Joanna Magdalena Rusecka, Maria Sklodowska-Curie Medical Academy, Warsaw, 00-136, Masovian, Poland
Camilla Ceccatelli Berti, University of Parma, Parma, 43121, Emilia-Romagna, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.